• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Repligen Corp (RGEN)

Common Shares
Sell: $146.80|Buy: $166.00|Change: 1.75 (1.17%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Address

41 Seyon Street, Building 1
Suite 100
Waltham
MA
USA
02453

Telephone

+1 781 4191881

Website

https://www.repligen.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Repligen Corp Third Quarter Earnings Conference Call for 20262026-10-28T08:30:00
Repligen Corp Third Quarter Earnings Results for 20262026-10-28T00:00:00
Repligen Corp Second Quarter Earnings Conference Call for 20262026-07-29T08:30:00
Repligen Corp Second Quarter Earnings Results for 20262026-07-29T00:00:00
Repligen Corp Annual General Meeting for 20262026-05-15T08:00:00
Repligen Corp First Quarter Earnings Conference Call for 20262026-04-29T08:30:00
Repligen Corp First Quarter Earnings Results for 20262026-04-29T00:00:00
Repligen Corp Annual Report for 20252026-03-13T00:00:00
Repligen Corp Fourth Quarter Earnings Conference Call for 20252026-02-20T08:30:00
Repligen Corp Fourth Quarter Earnings Results for 20252026-02-20T00:00:00

Previous key dates

NameKey Date
Repligen Corp Fourth Quarter Earnings Conference Call for 20252026-02-20T08:30:00
Repligen Corp Fourth Quarter Earnings Results for 20252026-02-20T00:00:00
8(th) Annual Evercore Healthcare Conference2025-12-03T13:20:00
Repligen Corp Third Quarter Earnings Conference Call for 20252025-10-28T08:30:00
Repligen Corp Third Quarter Earnings Result for 20252025-10-28T00:00:00
The Bank of America Global Healthcare Conference2025-09-25T06:35:00
The Deutsche Bank Healthcare Summit2025-09-10T00:00:00
The Wells Fargo Healthcare Conference2025-09-04T08:00:00
Repligen Corp Second Quarter Earnings Conference Call for 20252025-07-29T08:30:00
Repligen Corp Second Quarter Earnings Result for 20252025-07-29T00:00:00
Repligen Corp Annual General Meeting for 20252025-05-15T08:00:00
Repligen Corp First Quarter Earnings Conference Call for 20252025-04-29T08:30:00
Repligen Corp First Quarter Earnings Result for 20252025-04-29T00:00:00
Repligen Corp Annual Report for 20242025-03-14T00:00:00
Repligen Corp Fourth Quarter Earnings Conference Call for 20242025-02-20T08:30:00
Repligen Corp Fourth Quarter Earnings Result for 20242025-02-20T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.